Free Trial

Caligan Partners Lp Top Holdings and 13F Report (2024)

About Caligan Partners Lp

Investment Activity

  • Caligan Partners Lp has $394.88 million in total holdings as of June 30, 2024.
  • Caligan Partners Lp owns shares of 14 different stocks, but just 7 companies or ETFs make up 80% of its holdings.
  • Approximately 13.42% of the portfolio was purchased this quarter.
  • About 1.73% of the portfolio was sold this quarter.
  • This quarter, Caligan Partners Lp has purchased 12 new stocks and bought additional shares in 5 stocks.
  • Caligan Partners Lp sold shares of 1 stock and completely divested from 2 stocks this quarter.

Largest Holdings

Liquidia
$115,527,564
Verona Pharma
$66,728,614
Exelixis
$50,806,809
Evolus
$29,723,964
Anika Therapeutics
$23,622,240

Largest New Holdings this Quarter

Sage Therapeutics
$16,575,281 Holding
Merus
$10,722,750 Holding
ABIVAX SA
$5,505,862 Holding
Verrica Pharmaceuticals
$5,200,781 Holding

Largest Purchases this Quarter

Sage Therapeutics
3,052,538 shares (about $16.58M)
Merus
255,000 shares (about $10.72M)
Evolus
498,900 shares (about $5.51M)
ABIVAX SA
752,167 shares (about $5.51M)
Verrica Pharmaceuticals
7,429,687 shares (about $5.20M)

Largest Sales this Quarter

Enanta Pharmaceuticals
137,627 shares (about $791.36K)

Sector Allocation Over Time

Map of 500 Largest Holdings ofCaligan Partners Lp

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Liquidia Co. stock logo
LQDA
Liquidia
$115,527,5640.0%8,118,59229.3%Medical
Verona Pharma plc stock logo
VRNA
Verona Pharma
$66,728,6140.0%1,436,87816.9%Medical
Exelixis, Inc. stock logo
EXEL
Exelixis
$50,806,8090.0%1,525,73012.9%Medical
Evolus, Inc. stock logo
EOLS
Evolus
$29,723,964$5,507,856 22.7%2,692,3887.5%Medical
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
$23,622,2400.0%1,435,1306.0%Medical
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$22,529,409$3,100,849 16.0%2,995,9325.7%Medical
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
$20,579,561$1,530,060 8.0%626,2805.2%Medical
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$16,575,281$16,575,281 New Holding3,052,5384.2%Medical
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
$13,843,299$4,484,468 47.9%1,767,9823.5%Medical
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
$12,447,318$369,300 3.1%1,011,1553.2%Medical
Merus stock logo
MRUS
Merus
$10,722,750$10,722,750 New Holding255,0002.7%Medical
ABIVAX SA
$5,505,862$5,505,862 New Holding752,1671.4%SPONSORED ADS
Verrica Pharmaceuticals Inc. stock logo
VRCA
Verrica Pharmaceuticals
$5,200,781$5,200,781 New Holding7,429,6871.3%Medical
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$1,062,750$791,356 -42.7%184,8260.3%Medical
I-Mab stock logo
IMAB
I-Mab
$0$4,339,169 -100.0%00.0%Medical
OUTLOOK THERAPEUTICS INC
$0$1,701,853 -100.0%00.0%COM

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data